GCM
KMTS

Ghisallo Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Ghisallo Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
75,000
-101,992
-58% -$2.4M 0.04% 216
2025
Q4 		$4.69M Buy
176,992
+101,992
+136% +$2.63M 0.21% 98
2025
Q3 		$1.78M Hold
75,000
– – 0.06% 183
2025
Q2 		$1.24M Hold
75,000
– – 0.03% 163
2025
Q1 		$1.87M Buy
+75,000
New +$1.72M 0.16% 84

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ghisallo Capital Management's KMTS Position: Q1 2026 in Review

Ghisallo Capital Management reduced its Kestra Medical Technologies (KMTS) stake by 58% in Q1 2026, selling an estimated $2.4M and leaving 75,000 shares worth $1.49M. The position accounts for 0.04% of the portfolio, ranked #216.

Ghisallo Capital Management first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.69M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Ghisallo Capital Management held 75,000 shares of Kestra Medical Technologies worth $1.49M as of Q1 2026.
  • Ghisallo Capital Management sold 101,992 Kestra Medical Technologies shares in Q1 2026, an estimated $2.4M.
  • Kestra Medical Technologies made up 0.04% of Ghisallo Capital Management's portfolio in Q1 2026, its #216 holding.
  • Ghisallo Capital Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Ghisallo Capital Management's Kestra Medical Technologies position peaked at $4.69M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Ghisallo Capital Management's 13F filing for Q1 2026, filed 15 May 2026.